National Trends for Medicare Prescriptions of Antireflux Medications

Gastroenterology. 2020 Jul;159(1):378-380.e3. doi: 10.1053/j.gastro.2020.03.037. Epub 2020 Mar 25.

Authors

Ofer Z Fass¹, Kamrine E Poels²

Affiliations

¹ Department of Medicine, New York University Langone Health, New York, NY. Electronic address: ofer.fass@nyulangone.org.
² Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA.

PMID: 32222398
DOI: 10.1053/j.gastro.2020.03.037

No abstract available

Publication types

Comparative Study

MeSH terms

Administrative Claims, Healthcare / statistics & numerical data
Drug Prescriptions / statistics & numerical data*
Gastroesophageal Reflux / drug therapy*
Histamine H2 Antagonists / therapeutic use*
Humans
Medicare Part D / statistics & numerical data
Medicare Part D / trends*
Proton Pump Inhibitors / therapeutic use*
Sucralfate / therapeutic use*
United States

Substances

Histamine H2 Antagonists
Proton Pump Inhibitors
Sucralfate